A Gut Probiotic Didn’t Boost Blood Pressure Benefits From Dieting

If you already suspect your blood pressure problems trace back to your gut, a new trial has some sobering news. Researchers in Brazil tested whether adding a multi-strain probiotic to a calorie-restricted diet could improve arterial stiffness and blood pressure in adults with hypertension and excess weight, a group already carrying elevated cardiovascular risk. After 12 weeks, the probiotic added nothing measurable beyond what dieting alone achieved.

Key Takeaways

• A double-blind, placebo-controlled trial found no significant effect of a multi-strain probiotic on arterial stiffness or central blood pressure beyond a calorie-restricted diet alone.
• Losing body weight and visceral fat – not the probiotic – tracked with the modest improvements in artery measurements researchers did see.
• The trial was small (30 people had usable data on the primary vascular measures), so it cannot rule out a smaller benefit a larger study might catch.

Multi-Strain Probiotic Showed No Added Benefit for Arterial Stiffness

A double-blind, randomized, placebo-controlled trial found that an eight-strain probiotic supplement, taken daily for 12 weeks alongside an energy-restricted diet, produced no significant improvement in central hemodynamic parameters (measurements of blood pressure and stiffness taken directly at the aorta, the body's main artery) compared with a placebo. The capsule combined eight strains, including Lactobacillus acidophilus, Bifidobacterium lactis, and Bifidobacterium longum, delivering a total dose of about 30 billion colony-forming units (CFU) per day. The placebo group took visually identical capsules containing only microcrystalline cellulose, an inert filler, and both groups followed the same calorie-restricted eating plan throughout.

By week 12, neither group showed a statistically significant change in aortic systolic blood pressure, aortic pulse pressure, augmentation pressure, augmentation index, or pulse wave velocity (PWV, the speed at which a pressure wave travels through the arteries and a standard marker of stiffness). The formal statistical test comparing the probiotic group against the placebo group over time found no significant interaction for any of these measures, meaning the probiotic itself was not driving any difference between the groups. The study was published in Artery Research.

Why Arterial Stiffness Matters for People With Hypertension

Arterial stiffness matters because it predicts heart attacks, strokes, and death independent of a person's blood pressure reading at the doctor's office. As arteries lose their elasticity with age, disease, or excess weight, the heart works harder and organs receive blood in more forceful pulses; PWV is the standard, non-invasive way to measure it, and elevated PWV predicts cardiovascular events even after accounting for traditional risk factors like cholesterol and smoking, according to a review in the National Library of Medicine's PubMed Central archive. That makes this trial's population, adults ages 40 to 65 with existing hypertension and a body mass index between 25 and 39.9 (overweight through class 2 obesity), a group with real stakes in whether a supplement could meaningfully move these numbers.

A Small But Carefully Designed 12-Week Trial

The trial enrolled 66 adults at hypertension outpatient clinics affiliated with the State University of Rio de Janeiro, Brazil, running from December 2021 to March 2023, and it was registered in advance at Brazil's national clinical trials registry (RBR-7jw4ry). Participants were randomized using a computer-generated sequence concealed in sealed, opaque, sequentially numbered envelopes, and both participants and researchers stayed blinded to group assignment until the analysis was complete. Fifty-one participants completed the full 12 weeks (28 control, 23 probiotic), but due to technical and logistical issues compounded by the COVID-19 pandemic, only 30 of them (17 control, 13 probiotic) completed the full central-hemodynamics testing, using a tonometry-based SphygmoCor device and a Mobil-O-Graph oscillometric device to derive PWV. That is a small subgroup, but the researchers calculated in advance that a sample this size gave them 83.6% statistical power to detect a clinically meaningful 1 meter-per-second drop in PWV, and their effect-size calculations found no sign that a real but hard-to-detect probiotic benefit was hiding in the null results. Body composition, including visceral fat, was measured with dual-energy X-ray absorptiometry (DXA), the imaging method considered the gold standard for that purpose.

What This Means If You're Managing Blood Pressure Through Diet

If you are relying on diet changes to manage blood pressure, this trial's honest answer is that a probiotic supplement did not add extra benefit in this test, though the diet itself still mattered. Both groups followed the same reduced-calorie plan, roughly 800 fewer calories per day than each person's estimated energy needs, and both saw modest weight loss: 1.9% in the control group versus 1.0% in the probiotic group, a difference that was not statistically significant. What did track with better artery measurements was the weight loss itself: participants who lost more body weight saw larger drops in aortic systolic blood pressure and augmentation pressure, and those who lost more visceral fat (the fat around internal organs) saw larger drops in PWV. In other words, the caloric restriction, not the probiotic, appears to be doing the cardiovascular work here. That fits a broader pattern: a review of 26 trials found long-term probiotic use (8 weeks or more) linked to only modest average blood pressure reductions, around 2 mmHg, per a systematic review hosted by the National Library of Medicine, meaningfully smaller than what diet and weight loss alone typically deliver. Anyone considering a probiotic specifically for blood pressure should treat it as an unproven, modest-at-best add-on, not a substitute for the diet and medication changes a doctor recommends.

Small Sample Size and Blood Pressure Medication Use Limit the Findings

The clearest limitation is the trial's small size: only 13 people in the probiotic group had complete hemodynamic data, and the researchers themselves flagged that pandemic disruptions and strict eligibility rules shrank their planned sample. Every participant in this trial was also taking antihypertensive medication, unlike an earlier trial by Szulinska and colleagues, published in Nutrients in 2018, which found that a different multispecies probiotic did reduce PWV and blood pressure in postmenopausal women who were not on blood pressure drugs and were not simultaneously dieting. The Brazilian researchers argue that combination, active antihypertensive treatment plus caloric restriction, may have left less room for a probiotic to show a separate effect, since both interventions can already act on the same vascular pathways. A baseline imbalance in beta-blocker use (35% of the control group versus none of the probiotic group) did not change the results once the researchers statistically adjusted for it.

Researchers Call for Larger, Multicenter Trials Next

The study's authors are explicit that this null result does not close the door on the gut-artery connection; they call for larger, multicenter, blinded trials to properly test it. The biological rationale they cite involves gut-bacteria byproducts like TMAO (trimethylamine-N-oxide, a compound produced when gut microbes break down nutrients found in red meat and eggs), which has been linked to stiffer arteries and higher systolic blood pressure in animal and human research, according to a review of the gut-arterial stiffness connection. That mechanism remains plausible and worth testing further, the authors write, but this trial's own data show it did not translate into a measurable benefit under these particular conditions: hypertension medication use, concurrent caloric restriction, and a 30-person analysis sample.

Common Questions

Does this mean probiotics never help blood pressure? Not necessarily. Larger pooled analyses of many trials have found small average blood pressure reductions from probiotics generally, but this trial specifically tested whether adding one to a calorie-restricted diet provided extra benefit, and found none.

What actually improved participants' artery measurements in this trial? Weight loss, and specifically loss of visceral fat (fat around the internal organs), not the probiotic, correlated with better readings for aortic blood pressure and pulse wave velocity.

Should I stop taking a probiotic if I have high blood pressure? This trial doesn't suggest probiotics are harmful; it simply found no added cardiovascular benefit in this specific 12-week test. Any changes to blood pressure management are worth discussing with your doctor.

How did researchers measure arterial stiffness in this study? They used two non-invasive tools: a tonometry-based SphygmoCor device pressed against the wrist to model pressure inside the aorta, and a Mobil-O-Graph cuff device to calculate pulse wave velocity, the speed at which a pressure pulse travels through the arteries.

References

1. Marcella Rodrigues Guedes, Karine Scanci da Silva Pontes, Michelle Rabello da Cunha, Márcia Regina Simas Torres Klein (2026). Multi-strain Probiotic Does Not Enhance the Effects of Caloric Restriction on Central Hemodynamic Parameters in Individuals with Hypertension and Overweight. Artery Research. https://doi.org/10.1007/s44200-026-00137-8
2. Arterial stiffness and cardiovascular risk. NIH. https://pmc.ncbi.nlm.nih.gov/articles/PMC6506729/
3. Tian‐Xue Zhao, Li Zhang, Ning Zhou, Dong‐Sheng Sun, Jian‐Hong Xie, Shao‐Kun Xu (2022). Long‐term use of probiotics for the management of office and ambulatory blood pressure: A systematic review and meta‐analysis of randomized, controlled trials. Food Science & Nutrition. https://doi.org/10.1002/fsn3.3069
4. Monika Szulińska, Igor Łoniewski, Katarzyna Skrypnik, et al. (2018). Multispecies Probiotic Supplementation Favorably Affects Vascular Function and Reduces Arterial Stiffness in Obese Postmenopausal Women—A 12-Week Placebo-Controlled and Randomized Clinical Study. Nutrients. https://doi.org/10.3390/nu10111672
5. Gary L. Pierce, Stephen J. Roy, Colin J. Gimblet (2021). The Gut-Arterial Stiffness Axis: Is TMAO a Novel Target to Prevent Age-Related Aortic Stiffening?. Hypertension. https://doi.org/10.1161/hypertensionaha.121.17487